Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02034812 · ClinicalTrials.gov registry record
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists
A clinical trial, sponsored by GenomeDx Biosciences.
- Completed
- Registry status
- 25
- Enrollment target
NCT02034812: Completed study, sponsored by GenomeDx Biosciences.
NCT02034812 is a clinical trial that has completed, run by GenomeDx Biosciences. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02034812 has completed, sponsored by GenomeDx Biosciences.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This clinical utility study is based on a review of real but de-identified and randomized patient cases and aims to evaluate radiation oncologist's treatment recommendations before and after reviewing the results provided by the Decipher test. The primary intent is to help guide development and design of future clinical utility studies for Decipher.
Primary Outcome
Change in treatment recommendation from pre- to post-Decipher report, defined as any change in treatment recommendation.
Interventions
- OTHER Decipher Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-07 |
What the finished NCT02034812 record still lists
NCT02034812 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Decipher Questionnaire is the first listed.
NCT02034812 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02034812 about?
NCT02034812 is a clinical study titled "Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists". This clinical utility study is based on a review of real but de-identified and randomized patient cases and aims to evaluate radiation oncologist's treatment recommendations before and after reviewing the results provided by the Decipher test. The primary intent is to help guide development and desi...
What is the current status of trial NCT02034812?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2013-07. Estimated completion is 2014-07.
What interventions are being tested in trial NCT02034812?
The interventions under investigation include: Decipher Questionnaire (OTHER).
Who is sponsoring clinical trial NCT02034812?
This trial is sponsored by GenomeDx Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia